1. Home
  2. VYGR vs ALCO Comparison

VYGR vs ALCO Comparison

Compare VYGR & ALCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VYGR
  • ALCO
  • Stock Information
  • Founded
  • VYGR 2013
  • ALCO 1960
  • Country
  • VYGR United States
  • ALCO United States
  • Employees
  • VYGR N/A
  • ALCO N/A
  • Industry
  • VYGR Biotechnology: Pharmaceutical Preparations
  • ALCO
  • Sector
  • VYGR Health Care
  • ALCO
  • Exchange
  • VYGR Nasdaq
  • ALCO Nasdaq
  • Market Cap
  • VYGR 231.9M
  • ALCO 256.3M
  • IPO Year
  • VYGR 2015
  • ALCO N/A
  • Fundamental
  • Price
  • VYGR $4.95
  • ALCO $34.65
  • Analyst Decision
  • VYGR Strong Buy
  • ALCO
  • Analyst Count
  • VYGR 8
  • ALCO 0
  • Target Price
  • VYGR $16.71
  • ALCO N/A
  • AVG Volume (30 Days)
  • VYGR 814.4K
  • ALCO 20.1K
  • Earning Date
  • VYGR 11-11-2025
  • ALCO 12-01-2025
  • Dividend Yield
  • VYGR N/A
  • ALCO 0.58%
  • EPS Growth
  • VYGR N/A
  • ALCO N/A
  • EPS
  • VYGR N/A
  • ALCO N/A
  • Revenue
  • VYGR $42,580,000.00
  • ALCO $44,199,000.00
  • Revenue This Year
  • VYGR N/A
  • ALCO N/A
  • Revenue Next Year
  • VYGR $107.10
  • ALCO N/A
  • P/E Ratio
  • VYGR N/A
  • ALCO N/A
  • Revenue Growth
  • VYGR N/A
  • ALCO N/A
  • 52 Week Low
  • VYGR $2.65
  • ALCO $24.23
  • 52 Week High
  • VYGR $8.28
  • ALCO $35.49
  • Technical
  • Relative Strength Index (RSI)
  • VYGR 58.14
  • ALCO 61.64
  • Support Level
  • VYGR $4.72
  • ALCO $33.42
  • Resistance Level
  • VYGR $5.55
  • ALCO $35.49
  • Average True Range (ATR)
  • VYGR 0.35
  • ALCO 0.57
  • MACD
  • VYGR -0.01
  • ALCO 0.11
  • Stochastic Oscillator
  • VYGR 54.88
  • ALCO 65.79

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.

About ALCO Alico Inc.

Alico Inc is a Florida-based agribusiness and land management company that primarily focuses on citrus production and grove conservation. The company operates through two primary business units: Alico Citrus and Land Management and Other Operations. The Alico Citrus segment engages in the cultivation of citrus trees and delivers citrus to the processed and fresh citrus markets. It mainly serves the processed market and sells primarily Hamlin oranges and the Valencia variety to the orange juice processors. The Land Management and Other Operations segment engages in land leasing for recreational, conservation, and mining activities. Alico Citrus delivers most of the revenue as the firm's primary operating business unit.

Share on Social Networks: